High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
S Ananthan, ER Faaleolea, RC Goldman, JV Hobrath… - Tuberculosis, 2009 - Elsevier
There is an urgent need for the discovery and development of new antitubercular agents that
target new biochemical pathways and treat drug resistant forms of the disease. One …
target new biochemical pathways and treat drug resistant forms of the disease. One …
High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv.
S Ananthan, ER Faaleolea, RC Goldman… - Tuberculosis …, 2009 - europepmc.org
There is an urgent need for the discovery and development of new antitubercular agents that
target new biochemical pathways and treat drug resistant forms of the disease. One …
target new biochemical pathways and treat drug resistant forms of the disease. One …
[PDF][PDF] High Throughput Screening for Inhibitors of Mycobacterium tuberculosis H37Rv
S ANANTHAN1a, ER FAALEOLEA2a… - Tuberculosis …, 2009 - academia.edu
There is an urgent need for the discovery and development of new antitubercular agents that
target new biochemical pathways and treat drug resistant forms of the disease. One …
target new biochemical pathways and treat drug resistant forms of the disease. One …
[PDF][PDF] High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
S Ananthan, ER Faaleolea, RC Goldman, JV Hobrath… - Tuberculosis, 2009 - Citeseer
There is an urgent need for the discovery and development of new antitubercular agents that
target new biochemical pathways and treat drug resistant forms of the disease. One …
target new biochemical pathways and treat drug resistant forms of the disease. One …
[引用][C] High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
S Ananthan, ER Faaleolea, RC Goldman, JV Hobrath… - Tuberculosis, 2009 - cir.nii.ac.jp
High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
S Ananthan, ER Faaleolea, RC Goldman, JV Hobrath… - Tuberculosis, 2009 - infona.pl
There is an urgent need for the discovery and development of new antitubercular agents that
target new biochemical pathways and treat drug resistant forms of the disease. One …
target new biochemical pathways and treat drug resistant forms of the disease. One …
High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv.
S Ananthan, ER Faaleolea, RC Goldman, JV Hobrath… - 2009 - cabidigitallibrary.org
There is an urgent need for the discovery and development of new antitubercular agents that
target new biochemical pathways and treat drug resistant forms of the disease. One …
target new biochemical pathways and treat drug resistant forms of the disease. One …
High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
S Ananthan, ER Faaleolea… - Tuberculosis …, 2009 - pubmed.ncbi.nlm.nih.gov
There is an urgent need for the discovery and development of new antitubercular agents that
target new biochemical pathways and treat drug resistant forms of the disease. One …
target new biochemical pathways and treat drug resistant forms of the disease. One …
[HTML][HTML] High Throughput Screening for Inhibitors of Mycobacterium tuberculosis H37Rv
S ANANTHAN, ER FAALEOLEA… - Tuberculosis …, 2009 - ncbi.nlm.nih.gov
There is an urgent need for the discovery and development of new antitubercular agents that
target new biochemical pathways and treat drug resistant forms of the disease. One …
target new biochemical pathways and treat drug resistant forms of the disease. One …
High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
S Ananthan, ER Faaleolea… - Tuberculosis …, 2009 - pubmed.ncbi.nlm.nih.gov
There is an urgent need for the discovery and development of new antitubercular agents that
target new biochemical pathways and treat drug resistant forms of the disease. One …
target new biochemical pathways and treat drug resistant forms of the disease. One …